Is Microsoft an Undervalued Growth Stock to Buy?
Tech giant Microsoft (NASDAQ:MSFT) has been one of the biggest…
Sell
11
SCLX Quote, Financials, Valuation and Earnings
Last price:
$0.39
Seasonality move
:
46.27%
Day range:
$0.38 - $0.41
52-week range:
$0.38 - $2.63
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.88x
P/B ratio:
--
Volume:
1.6M
Avg. volume:
1.8M
1-year change:
-76.92%
Market cap:
$51.4M
Revenue:
$46.7M
EPS (TTM):
-$1.43
Analysts' Opinion
-
Consensus RatingScilex Holding has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.08, Scilex Holding has an estimated upside of 2229.06% from its current price of $0.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.25 representing 100% downside risk from its current price of $0.39.
Fair Value
-
According to the consensus of 1 analyst, Scilex Holding has 2229.06% upside to fair value with a price target of $9.08 per share.
SCLX vs. S&P 500
-
Over the past 5 trading days, Scilex Holding has underperformed the S&P 500 by -12.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Scilex Holding does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Scilex Holding has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Scilex Holding reported revenues of $16.4M.
Earnings Growth
-
Scilex Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Scilex Holding reported earnings per share of -$0.31.
Enterprise value:
148.9M
EV / Invested capital:
--
Price / LTM sales:
0.88x
EV / EBIT:
--
EV / Revenue:
2.93x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
12.85x
Price / Operating cash flow:
3.87x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$34.7M
Return On Assets:
-117.93%
Net Income Margin (TTM):
-233.88%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-95.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | -- | $46.5M | $50.8M | $12.6M | $16.4M | |
| Gross Profit | -- | $30.6M | $34.7M | $8.4M | $12M | |
| Operating Income | -- | -$78.6M | -$99.1M | -$22.8M | -$15.6M | |
| EBITDA | -- | -$41.5M | -$112.6M | -$25.6M | -$36M | |
| Diluted EPS | -- | -$0.38 | -$1.43 | -$0.19 | -$0.31 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $69.2M | $50.4M | |
| Total Assets | -- | -- | -- | $126.5M | $104.5M | |
| Current Liabilities | -- | -- | -- | $103.6M | $255.5M | |
| Total Liabilities | -- | -- | -- | $116M | $319.2M | |
| Total Equity | -- | -- | -- | $10.4M | -$214.7M | |
| Total Debt | -- | -- | -- | $34.4M | $104.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$19.4M | $12.2M | -$13.5M | $2.3M | |
| Cash From Investing | -- | -$15K | -$622K | -$8K | -$150K | |
| Cash From Financing | -- | $47.7M | -$37.1M | $43.5M | $4.7M | |
| Free Cash Flow | -- | -$19.4M | $11.6M | -$13.5M | $2.2M | |
SCLX
Sector
Market Cap
$51.4M
$45.9M
Price % of 52-Week High
14.83%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
-22.79%
-0.6%
1-Year Price Total Return
-76.92%
-32.15%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.44
200-day SMA
Sell
Level
$1.12
Bollinger Bands (100)
Sell
Level
0.63 - 1.13
Chaikin Money Flow
Sell
Level
-87.4M
20-day SMA
Sell
Level
$0.54
Relative Strength Index (RSI14)
Sell
Level
27.60
ADX Line
Sell
Level
17.25
Williams %R
Buy
Level
-97.151
50-day SMA
Sell
Level
$0.71
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Sell
Level
-32.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-11.9676)
Sell
CA Score
(Annual)
Level (-11.343)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (21.398)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Stock Forecast FAQ
In the current month, SCLX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SCLX average analyst price target in the past 3 months is $9.08.
-
Where Will Scilex Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that Scilex Holding share price will rise to $9.08 per share over the next 12 months.
-
What Do Analysts Say About Scilex Holding?
Analysts are divided on their view about Scilex Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Scilex Holding is a Sell and believe this share price will drop from its current level to $6.25.
-
What Is Scilex Holding's Price Target?
The price target for Scilex Holding over the next 1-year time period is forecast to be $9.08 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SCLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Scilex Holding is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SCLX?
You can purchase shares of Scilex Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Scilex Holding shares.
-
What Is The Scilex Holding Share Price Today?
Scilex Holding was last trading at $0.39 per share. This represents the most recent stock quote for Scilex Holding. Yesterday, Scilex Holding closed at $0.39 per share.
-
How To Buy Scilex Holding Stock Online?
In order to purchase Scilex Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
